Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
1.040
-0.030 (-2.80%)
Nov 20, 2024, 4:00 PM EST - Market closed

Co-Diagnostics Revenue

Co-Diagnostics had revenue of $641.14K in the quarter ending September 30, 2024, a decrease of -73.91%. This brings the company's revenue in the last twelve months to $7.32M, up 57.16% year-over-year. In the year 2023, Co-Diagnostics had annual revenue of $6.81M, down -80.09%.

Revenue (ttm)
$7.32M
Revenue Growth
+57.16%
P/S Ratio
4.26
Revenue / Employee
$47,232
Employees
155
Market Cap
33.21M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20236.81M-27.41M-80.09%
Dec 31, 202234.22M-63.67M-65.04%
Dec 31, 202197.89M23.33M31.30%
Dec 31, 202074.55M74.34M34,579.90%
Dec 31, 2019214.97K175.06K438.63%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
FibroGen 180.02M
HOOKIPA Pharma 50.00M
Precision Optics Corporation 18.98M
Surrozen 10.00M
Moolec Science 5.63M
Revenue Rankings